INDUCTION OF LUNG-TUMORS AND LYMPHOMAS IN BALB/C MICE BY METRONIDAZOLE

被引：27

作者：

CAVALIERE, A ^{[1
]}

BACCI, M ^{[1
]}

AMOROSI, A ^{[1
]}

DELGAUDIO, M ^{[1
]}

VITALI, R ^{[1
]}

机构：

[1] UNIV PERUGIA,IST IGIENE,I-06100 PERUGIA,ITALY

来源：

TUMORI | 1983年 / 69卷 / 05期

关键词：

D O I：

10.1177/030089168306900502

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：379 / 382

页数：4

相关论文

共 14 条

[1] LACK OF EVIDENCE FOR CANCER DUE TO USE OF METRONIDAZOLE
BEARD, CM
NOLLER, KL
OFALLON, WM
KURLAND, LT
DOCKERTY, MB
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1979, 301 (10) : 519 - 522
[2] CONNOR TH, 1977, CANCER RES, V37, P629
[3] FRIEDMAN GD, 1980, NEW ENGL J MED, V302, P519
[4] GOODMAN LS, 1975, PHARM BASIS THERAPEU, P1072
[5] JACKSON B, 1961, LAB INVEST, V10, P909
[6] KOCH RL, 1979, J PHARMACOL EXP THER, V208, P406
[7] ACETAMIDE - METABOLITE OF METRONIDAZOLE FORMED BY THE INTESTINAL FLORA
KOCH, RL
CHRYSTAL, EJT
BEAULIEU, BB
GOLDMAN, P
[J]. BIOCHEMICAL PHARMACOLOGY, 1979, 28 (24) : 3611 - 3615
[8] A METRONIDAZOLE METABOLITE IN HUMAN-URINE AND ITS RISK
KOCH, RL
BEAULIEU, BB
CHRYSTAL, EJT
GOLDMAN, P
[J]. SCIENCE, 1981, 211 (4480) : 398 - 400
[9] DESIGN AND ANALYSIS OF RANDOMIZED CLINICAL-TRIALS REQUIRING PROLONGED OBSERVATION OF EACH PATIENT .2. ANALYSIS AND EXAMPLES
PETO, R
PIKE, MC
ARMITAGE, P
BRESLOW, NE
COX, DR
HOWARD, SV
MANTEL, N
MCPHERSON, K
PETO, J
SMITH, PG
[J]. BRITISH JOURNAL OF CANCER, 1977, 35 (01) : 1 - 39
[10] Peto R, 1980, IARC Monogr Eval Carcinog Risk Chem Hum Suppl, P311